You may be able to take part in this study if you:

• are 18 years of age or older

• have chronic kidney disease (CKD) but you are not on dialysis

• already take a medication such as Procrit (R), Eprex (R), Mircera (R), Neorecormon (R), Epogen (R), or Aranesp TM [darbepoetin alfa] for anemia

• have not had an organ transplant and are not due to have a kidney transplant

​

​

Participation in the PRO2Tect - CONVERSION Study will last between 1.5 and 4 years and will require regular visits to the studycenter. The study medication (potential new medication and approved anemia medication) and allstudy-related assesments will be provided at no cost to you.

​

If you are interested in learning more about this study, please contact:

​

​